Lawsuit Information Center

June 19, 2026

Gabapentin Dementia Lawsuit

Gabapentin lawsuits are now being investigated because new research has raised concerns that long-term or repeated gabapentin use is linked to dementia, mild cognitive impairment, memory loss, confusion, and other cognitive problems.

These cases are still developing, and we are in the early rounds of this. There is no nationwide gabapentin dementia MDL, no approved class action settlement, and no guaranteed payout. But the science is advancing, and the legal theories are strengthening as the evidence grows.

Gabapentin is one of the most commonly prescribed medications in the United States. It is sold under the brand name Neurontin and is also available as a generic. Doctors prescribe Neurontin for seizures, shingles-related nerve pain, and a long list of off-label conditions, including back pain, neuropathy, anxiety, migraines, fibromyalgia, sleep problems, and other chronic pain complaints.

June 18, 2026

California Birth Injury Lawsuits

by Ronald V. Miller, Jr.

California birth injury lawsuits are about holding doctors, nurses, hospitals, urgent care clinics, OB practices, and other health care providers accountable when preventable medical mistakes cause real harm to the child during the labor and delivery process. But the most devastating California malpractice cases our lawyers see are birth injury lawsuits. Birth injury cases are different. A missed diagnosis in an adult case can ruin a life. A negligent delivery can ruin the life of a child before that child ever gets a fair start. It can also change the parents’ lives forever.

These are the cases where the parents walk into the hospital expecting one of the happiest days of their lives, and they leave with a baby who has brain damage, seizures, cerebral palsy, a brachial plexus injury, or a lifetime need for medical care. That is hard to write. But it is the truth.

California birth injury lawsuits often focus on whether doctors and nurses failed to recognize fetal distress, delayed a C-section, mismanaged Pitocin, ignored abnormal fetal heart tracings, mishandled shoulder dystocia, failed to treat maternal infection, failed to respond to placental abruption, or failed to properly resuscitate the baby after delivery.

June 18, 2026

Oxbryta Lawsuit Settlement

by Ronald V. Miller, Jr.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading

June 18, 2026

Camp Lejeune Lawsuit News and Updates

by Ronald V. Miller, Jr.

This page provides updates on Camp Lejeune lawsuits. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

Latest Camp Lejeune Lawsuit Updates for 2026

June 17, 2026

Olympus Scope Lawsuit

by Ronald V. Miller, Jr.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died. The infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat. The patients had gone into the hospital for diagnostic or therapeutic procedures involving the bile ducts or pancreas, including gallstone evaluations, pancreatic biopsies, and bile duct imaging. Some came out with infections that damaged organs, required months of intensive care, or proved fatal.

The remarkable part is not simply that it happened. Medical devices fail. Infections occur. What makes the Olympus duodenoscope litigation extraordinary is what plaintiffs allege Olympus knew. Olympus knew its scopes could not be reliably cleaned. Olympus knew that bacteria were surviving the reprocessing process and spreading from patient to patient. Olympus knew that patients were dying. And for years, the company failed to respond with the urgency patient safety required.

This page explains what went wrong, why it went wrong, and the legal options available to patients and families harmed by contaminated Olympus scopes. It is written for people who want to understand not just the claims being filed, but the science, the regulatory failures, and the corporate decisions that turned a solvable engineering problem into a public health catastrophe.

June 17, 2026

Internal Bra Mesh Lawsuit

by Ronald V. Miller, Jr.

Breast mesh lawsuits allege that some manufacturers promoted or allowed their mesh products to become widely used in breast reconstruction, augmentation, and revision procedures despite the fact that FDA has not cleared or approved any surgical mesh product for use in breast surgery. The FDA has specifically stated that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined.

These internal bra lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.

This page explains the internal bra mesh lawsuit. Our lawyers talk about what the legal claims are, who may be eligible, what complications may qualify, how to identify your mesh product, what evidence matters, and what these cases may be worth.

June 17, 2026

Bard PowerPort Lawsuit

by Ronald V. Miller, Jr.

The Bard PowerPort (“BardPort”) is a port catheter device implanted just under the skin to allow for easy attachment to a catheter for the intravenous delivery of fluids or medication.

The Bard PowerPort has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position. This can cause severe injuries, including internal vascular damage.

Individuals who suffered injuries due to a defective Bard PowerPort device are now bringing product liability lawsuits against the manufacturer of the PowerPort implants. Our firm is currently accepting new cases from anyone who had a Bard PowerPort port catheter device implanted and was injured due to a fracture, migration, or other implant failures.

June 17, 2026

AFFF Firefighting Foam Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling AFFF firefighting foam lawsuits around the country.

This page provides the most recent news and updates on the AFFF firefighting foam class action lawsuit and our prediction of the settlement amounts that plaintiffs with AFFF cancer lawsuits can expect to receive. You will not get more updated news on the AFFF litigation anywhere else.

Our AFFF firefighting foam lawyers believe the defendants will settle most of these lawsuits this year (2026) before a single trial. Why? They will follow the same pattern as the water contamination lawsuits they settled for billions of dollars. In those cases, we saw the defendants’ apparent preference for settlement over the uncertainties of a trial. This makes sense; the AFFF lawsuits are strong cases.

June 16, 2026

Maine Injury Settlements and Verdicts (and law)

by Ronald V. Miller, Jr.

Ten years ago, I posted data showing the average personal injury verdict in Maine was approximately $27,000. These numbers do not tend to change much historically. So my guess is the average personal injury settlement in Maine is between $25,000 and $40,000.

But you have to understand how useless that is if you have a personal injury claim in Maine and you are trying to calculate or predict your settlement compensation payout.

Sample settlements and verdicts are not necessarily much better at projecting settlement amounts. But these are weapons you can use to better understand potential settlement compensation for an injury case in Maine.

June 16, 2026

Grok AI Deepfake Lawsuit

by Ronald V. Miller, Jr.

Artificial intelligence has changed how people create, edit, and distribute images. But it has also opened a dangerous new frontier for exploitation and abuse. One of the most alarming developments is the rise of AI-generated sexual deepfakes: fake images or videos that can make it appear as though a real person was nude, sexualized, or involved in conduct that never happened.

The Grok deepfake lawsuit is one of the clearest early tests of whether AI companies can be held legally responsible when their tools generate or enable nonconsensual sexual images. These claims are not just about bad users. They are about product design, warnings, safeguards, profit, notice, and whether a company can release a powerful image-generation tool into the world and then blame victims when the predictable abuse occurs.

If your image, your child’s image, or someone you love was used in an AI-generated sexual deepfake, treat it like evidence in a serious civil case. Because it is. Screenshots help, but URLs, account names, timestamps, takedown requests, medical records, school records, employment records, and platform responses can all help. You do not need every piece of evidence to call, but the more we can preserve, the stronger the case may be.